Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Microalbuminuria.

Literature DB >> 1515784

Microalbuminuria.

P H Winocour.

Abstract

Mesh：

Year: 1992 PMID： 1515784 PMCID： PMC1881757 DOI： 10.1136/bmj.304.6836.1196

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

27 in total

1. Microalbuminuria and associated cardiovascular risk factors in the community.

Authors: P H Winocour; J O Harland; J P Millar; M F Laker; K G Alberti
Journal: Atherosclerosis Date: 1992-03 Impact factor: 5.162

2. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.

Authors: P H Winocour; D Bhatnagar; M Ishola; S Arrol; P N Durrington
Journal: Diabet Med Date: 1991-12 Impact factor: 4.359

3. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.

Authors: P H Winocour; P N Durrington; D Bhatnagar; M Ishola; M Mackness; S Arrol
Journal: Atherosclerosis Date: 1991-07 Impact factor: 5.162

4. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors: S D Elek; H Stern
Journal: Lancet Date: 1974-01-05 Impact factor: 79.321

5. Haemostatic measures in type 2 diabetic patients with microalbuminuria.

Authors: A Schmitz; J Ingerslev
Journal: Diabet Med Date: 1990-07 Impact factor: 4.359

6. The natural history of diabetic autonomic neuropathy.

Authors: D J Ewing; I W Campbell; B F Clarke
Journal: Q J Med Date: 1980

7. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.

Authors: C J Bulpitt; L J Beilin; P Clifton; E C Coles; C T Dollery; J S Gear; G S Harper; B F Johnson; A D Munro-Faure
Journal: Lancet Date: 1979-07-21 Impact factor: 79.321

8. Increased transcapillary escape rate of albumin and IgG in essential hypertension.

Authors: H H Parving; H A Jensen; M Westrup
Journal: Scand J Clin Lab Invest Date: 1977-05 Impact factor: 1.713

Review 9. Screening for microalbuminuria: which measurement?

Authors: S M Marshall
Journal: Diabet Med Date: 1991-10 Impact factor: 4.359

10. Platelet behaviour and haemostatic variables in type 1 (insulin-dependent) diabetic patients with and without albuminuria.

Authors: M J O'Donnell; C A Le Guen; N Lawson; O H Gyde; A H Barnett
Journal: Diabet Med Date: 1991 Aug-Sep Impact factor: 4.359

5 in total

Microalbuminuria.

1. Microalbuminuria and associated cardiovascular risk factors in the community.

2. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.

3. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.

4. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

5. Haemostatic measures in type 2 diabetic patients with microalbuminuria.

6. The natural history of diabetic autonomic neuropathy.

7. Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.

8. Increased transcapillary escape rate of albumin and IgG in essential hypertension.

Review 9. Screening for microalbuminuria: which measurement?

10. Platelet behaviour and haemostatic variables in type 1 (insulin-dependent) diabetic patients with and without albuminuria.

1. Urine albumin, total protein, and glomerular proteinuria.

2. Assessment of kidney function: UACR--two risk markers or a 24 h collection in a minute?

3. Estimating urinary albumin excretion rate of diabetic patients in clinical practice.

4. Early renal effects of occupational exposure to low-level hexavalent chromium.

5. Arterial hypertension assessment in a population with chronic myeloid leukemia.